Abbott Korea to reduce Reductil price by 40%.

The price of Reductil, an anti-obesity drug supplied by Abbott Korea, will be reduced by 40% taking effect from July 9 for promotion of the product access to more fat consumers.

A staff of Abbott Korea said "Our own market research found out that only 5 to 10% of fat patients received a treatment, and therefore we determined to reduce the price to increase more access of the obese patients i...